JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB240639

Anti-RUNX1 / AML1 antibody [EPR23044-100]

  • BOND RX™ Validated
  • Recombinant
  • Advanced Validation
  • RabMAb
  • What is this?

4

(14 Reviews)

|

(14 Publications)

Rabbit Recombinant Monoclonal RUNX1 / AML1 antibody. Suitable for ChIC/CUT&RUN-seq, IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 14 publications.

View Alternative Names

AML1, CBFA2, RUNX1, Runt-related transcription factor 1, Acute myeloid leukemia 1 protein, Core-binding factor subunit alpha-2, Oncogene AML-1, Polyomavirus enhancer-binding protein 2 alpha B subunit, SL3-3 enhancer factor 1 alpha B subunit, SL3/AKV core-binding factor alpha B subunit, CBF-alpha-2, PEA2-alpha B, PEBP2-alpha B

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Immunohistochemical analysis of paraffin-embedded Human breast tissue labeling RUNX1 / AML1 with ab240639 at 1/2000 dilution (0.25 ug/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human breast tissue is observed. The section was incubated with ab240639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

Immunocytochemistry/ Immunofluorescence - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized Jurkat (Human T cell leukemia T lymphocyte) cells labelling RUNX1 / AML1 with ab240639 at 1/100 dilution, followed by ab240639 anti-RUNX1/AML1 ab150077 AlexaFluor®488 Goat anti-Rabbit secondary antibody at 1/1000 dilution (Green). Confocal image showing strong nuclear and weak cytoplasmic staining in Jurkat cell line is observed. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).

Secondary antibody only control : Secondary antibody is ab240639 anti-RUNX1/AML1 ab150077 AlexaFluor®488 Goat anti-Rabbit secondary at 1/1000 dilution.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Immunohistochemical analysis of paraffin-embedded Human breast carcinoma tissue labeling RUNX1 / AML1 with ab240639 at 1/2000 dilution (0.25 ug/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining on human breast carcinoma (PMID : 24967588) tissue is observed. The section was incubated with ab240639 for 15 mins at room temperature. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.

Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

Flow Cytometry (Intracellular) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Intracellular flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized Jurkat (Human T cell leukemia T lymphocyte) cells labelling RUNX1 / AML1 with ab240639 at 1/500 (Red) compared with a Rabbit monoclonal IgG (ab172730, Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • IP

Unknown

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

RUNX1 / AML1 was immunoprecipitated from 0.35 mg Jurkat (human T cell leukemia T lymphocyte) whole cell lysate 10ug with ab240639 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab240639 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution. Lane 1 : Jurkat (human T cell leukemia T lymphocyte) whole cell lysate 10ug

Lane 2 : ab240639 IP in Jurkat whole cell lysate

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab240639 in Jurkat whole cell lysate

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 10 seconds

All lanes:

Immunoprecipitation - Anti-RUNX1 / AML1 antibody [EPR23044-100] (ab240639)

Predicted band size: 48 kDa

false

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • WB

Lab

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Western blot : Rabbit Monoclonal [EPR23044-100] to RUNX1 / AML1 ab240639 staining at a 1/200 dilution, shown in black; Mouse anti-CANX (ab238078) loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 50-54 kDa in Wild-type U-87 MG cell lysates with no signal observed at this size in RUNX1 knockout U-87 MG cell line.

To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit HRP (H+L) & Goat anti-Mouse 680RD at 1/20,000 dilution.

Lanes 1 - 4:

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (ab240639) at 1/200 dilution

Lanes 1 - 4:

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/runx1-aml1-antibody-epr23044-100-bsa-and-azide-free-ab264471'>ab264471</a>) at 1/200 dilution

Lane 1:

Wild-type U-87 MG at 40 µg

Lane 2:

Western blot - Human RUNx1 knockout U-87 MG cell line (ab306773) at 40 µg

Lane 3:

Jurkat at 20 µg

Lane 4:

Caco-2 at 20 µg

Secondary

All lanes:

Goat anti-Rabbit HRP (H+L) & Goat anti-Mouse 680RD at 1/20000 dilution

Predicted band size: 48 kDa

Observed band size: 50-54 kDa

true

Exposure time: 10s

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • WB

Lab

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

Blocking and diluting buffer and concentration : 5% NFDM/TBST The expression profile/ molecular weight observed is consistent with what has been described in the literature (PMID : 23352661, 29296779). The RUNX1 gene has several isoforms, 3 major isotypes. RUNX1b is broadly expressed, and RUNX1a overexpression has been reported in AML.

Exposure time : Lane 1 : 48 seconds Lanes 2-3 : 26 seconds

All lanes:

Western blot - Anti-RUNX1 / AML1 antibody [EPR23044-100] (ab240639) at 1/1000 dilution

Lane 1:

THP-1 (human monocytic leukemia monocyte), whole cell lysate at 10 µg

Lane 2:

Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 10 µg

Lane 3:

MOLT-4 (human lymphoblastic leukemia T lymphoblast), whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 48 kDa

Observed band size: 27-55 kDa

false

ChIC/CUT&RUN sequencing - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)
  • ChIC/CUT&RUN-seq

Supplier Data

ChIC/CUT&RUN sequencing - Anti-RUNX1 / AML1 antibody [EPR23044-100] (AB240639)

ChIC/CUT&RUN was performed using a pAG-MNAse at a final concentration of 700 ng/mL, 2.5 x 10^5 K-562 (Human chronic myelogenous leukemia lymphoblast) cells and 5µg of ab240639 [EPR23044-100]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown. Additional screenshots of mapped reads can be found in the Protocol booklet in the Product Protocol section. The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.

  • Carrier free

    Anti-RUNX1 / AML1 antibody [EPR23044-100] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR23044-100

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, ICC/IF, IP, ChIC/CUT&RUN-seq, WB, Flow Cyt (Intra)

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ChICCUTRUNseq" : {"fullname" : "ChIC/CUT&RUN sequencing", "shortname":"ChIC/CUT&RUN-seq"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ChIP" : {"fullname" : "ChIP", "shortname":"ChIP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ChICCUTRUNseq-species-checked": "testedAndGuaranteed", "ChICCUTRUNseq-species-dilution-info": "5 µg", "ChICCUTRUNseq-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "ChIP-species-checked": "notRecommended", "ChIP-species-dilution-info": "", "ChIP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/500", "FlowCytIntra-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/2000", "IHCP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

RUNX1 also known as AML1 is a transcription factor with a molecular weight of approximately 48 kDa. It belongs to the Runt-related transcription factor family and plays a critical role in hematopoiesis. RUNX1 is expressed in hematopoietic stem cells and various other tissues where it regulates the expression of genes involved in the differentiation and proliferation of blood cells. It exerts its function by binding to specific DNA sequences thereby controlling the transcriptional activity necessary for normal hematopoietic development.
Biological function summary

RUNX1 is essential in the formation of blood cells and is part of the core-binding factor (CBF) complex. This complex is a heterodimer comprising RUNX1 and the CBFβ subunit. The interaction between RUNX1 and CBFβ stabilizes the DNA binding capability of RUNX1 facilitating the activation of target gene transcription. The proper functioning of RUNX1 is necessary for the maintenance of normal lineage specification of hematopoietic progenitors affecting both myeloid and lymphoid cell lineages.

Pathways

RUNX1 plays a significant role in the Wnt signaling pathway and the TGF-beta signaling pathway. RUNX1 interacts with several proteins in these pathways including SMAD proteins and β-catenin which are important for transmitting extracellular signals that regulate cell growth and differentiation. RUNX1’s role in these pathways highlights its importance not only in hematopoiesis but also in preventing abnormal cell proliferation.

RUNX1 mutations are strongly associated with acute myeloid leukemia (AML) and familial platelet disorder. In AML RUNX1 mutations disrupt normal hematopoiesis leading to the uncontrolled proliferation of immature blood cells. RUNX1-related proteins such as the GM-CSF receptor can contribute to disease progression by altering cytokine signaling. RUNX1's involvement in familial platelet disorder reflects its importance in maintaining normal blood cell counts and function as loss of RUNX1 function leads to predisposition to leukemia.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Forms the heterodimeric complex core-binding factor (CBF) with CBFB. RUNX members modulate the transcription of their target genes through recognizing the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-TGCGGT-3', within their regulatory regions via their runt domain, while CBFB is a non-DNA-binding regulatory subunit that allosterically enhances the sequence-specific DNA-binding capacity of RUNX. The heterodimers bind to the core site of a number of enhancers and promoters, including murine leukemia virus, polyomavirus enhancer, T-cell receptor enhancers, LCK, IL3 and GM-CSF promoters (Probable). Essential for the development of normal hematopoiesis (PubMed : 17431401). Acts synergistically with ELF4 to transactivate the IL-3 promoter and with ELF2 to transactivate the BLK promoter (PubMed : 10207087, PubMed : 14970218). Inhibits KAT6B-dependent transcriptional activation (By similarity). Involved in lineage commitment of immature T cell precursors. CBF complexes repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell development. They bind to RUNX-binding sequence within the ZBTB7B locus acting as transcriptional silencer and allowing for cytotoxic T cell differentiation. CBF complexes binding to the transcriptional silencer is essential for recruitment of nuclear protein complexes that catalyze epigenetic modifications to establish epigenetic ZBTB7B silencing (By similarity). Controls the anergy and suppressive function of regulatory T-cells (Treg) by associating with FOXP3. Activates the expression of IL2 and IFNG and down-regulates the expression of TNFRSF18, IL2RA and CTLA4, in conventional T-cells (PubMed : 17377532). Positively regulates the expression of RORC in T-helper 17 cells (By similarity).. Isoform AML-1G shows higher binding activities for target genes and binds TCR-beta-E2 and RAG-1 target site with threefold higher affinity than other isoforms. It is less effective in the context of neutrophil terminal differentiation.. Isoform AML-1L interferes with the transactivation activity of RUNX1.
See full target information RUNX1

Publications (14)

Recent publications for all applications. Explore the full list and refine your search

Open life sciences 20:20251157 PubMed40917776

2025

RUNX1 promotes denervation-induced muscle atrophy by activating the JUNB/NF-κB pathway and driving M1 macrophage polarization.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Hu,Yang Huang,Wei Yin,Yao Huang,Jian Wu

Nature communications 16:3312 PubMed40204713

2025

GRAMD1B is a regulator of lipid homeostasis, autophagic flux and phosphorylated tau.

Applications

Unspecified application

Species

Unspecified reactive species

Diana Acosta Ingram,Emir Turkes,Tae Yeon Kim,Sheeny Vo,Nicholas Sweeney,Marie-Amandine Bonte,Ryan Rutherford,Dominic L Julian,Meixia Pan,Jacob Marsh,Andrea R Argouarch,Min Wu,Douglas W Scharre,Erica H Bell,Lawrence S Honig,Jean Paul Vonsattel,Geidy E Serrano,Thomas G Beach,Celeste M Karch,Aimee W Kao,Mark E Hester,Xianlin Han,Hongjun Fu

Frontiers in immunology 15:1430136 PubMed39822248

2025

Novel biomarkers: the RUNX family as prognostic predictors in colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yingting Liu,Junjun Chen,An Li,Yue Wu,Junwei Ge,Maoling Yuan,Bin Xu,Xiao Zheng,Lujun Chen,Jingting Jiang

Cell biology and toxicology 41:21 PubMed39753834

2025

Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yunhao Wu,Nu Li,Jin Shang,Jiazi Jiang,Xiaoliang Liu

Nature cell biology 26:1984-1996 PubMed39379702

2024

Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart.

Applications

Unspecified application

Species

Unspecified reactive species

Miriana Dardano,Felix Kleemiß,Maike Kosanke,Dorina Lang,Liam Wilson,Annika Franke,Jana Teske,Akshatha Shivaraj,Jeanne de la Roche,Martin Fischer,Lucas Lange,Axel Schambach,Lika Drakhlis,Robert Zweigerdt

Communications biology 7:1131 PubMed39271940

2024

RUNX1 interacts with lncRNA SMANTIS to regulate monocytic cell functions.

Applications

Unspecified application

Species

Unspecified reactive species

Lisa M Weiss,Timothy Warwick,Simonida Zehr,Stefan Günther,Sebastian Wolf,Tessa Schmachtel,Judit Izquierdo Ponce,Katalin Pálfi,Tom Teichmann,Alicia Schneider,Julia Stötzel,Stefan Knapp,Andreas Weigert,Rajkumar Savai,Michael A Rieger,Thomas Oellerich,Ilka Wittig,James A Oo,Ralf P Brandes,Matthias S Leisegang

Cell death discovery 9:150 PubMed37156809

2023

GATA4-activated lncRNA MALAT1 promotes osteogenic differentiation through inhibiting NEDD4-mediated RUNX1 degradation.

Applications

Unspecified application

Species

Unspecified reactive species

Xianzhe Huang,Shuo Jie,Wenzhao Li,Chan Liu

The Journal of biological chemistry 299:104677 PubMed37028765

2023

VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner.

Applications

Unspecified application

Species

Unspecified reactive species

Zi-Qi Zheng,Zhuo-Hui Huang,Ye-Lin Liang,Wei-Hong Zheng,Cheng Xu,Zhi-Xuan Li,Na Liu,Pan-Yang Yang,Ying-Qin Li,Jun Ma,Ying Sun,Ling-Long Tang,Denghui Wei

Cell death & disease 14:207 PubMed36949071

2023

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjin Qiu,Zumu Xiao,Yushi Yang,Lishi Jiang,Shibin Song,Xiaolan Qi,Yimin Chen,Hua Yang,Jian Liu,Liangzhao Chu

Frontiers in immunology 14:1086280 PubMed36776876

2023

RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Hao Zhang,Hui Cao,Hong Luo,Nan Zhang,Zeyu Wang,Ziyu Dai,Wantao Wu,Guodong Liu,Zongyi Xie,Quan Cheng,Yuan Cheng
View all publications
chicCutRunSequencingBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com